• Tidak ada hasil yang ditemukan

Forest plantations urged to invest in R&D on pest and disease

N/A
N/A
Protected

Academic year: 2023

Membagikan "Forest plantations urged to invest in R&D on pest and disease"

Copied!
1
0
0

Teks penuh

(1)

Forest plantations urged to invest in R&D on pest and disease

KUCHING: Globally, pests and diseases have caused many forest plantations to fail, call- ing for greater investment in new technologies and capac- ity-building in planted for- est research and development (R&D) to forestall the devasta- tions that can be brought by these threats.

This was the central message delivered to the 50 participants at a 'Pest and Disease' workshop held here on Monday.

Driving home this point was world-renowned tree health expert and president of the International Union of Forest Research Organisations (IUFRO) Professor Michael J.

Wingfield.

The workshop was part of the Planted Forest Research Program (PFRP) implemented by Sarawak Forestry Corporation (SFC) to facilitate the establishment of planted forests in Sarawak.

Wingfield, in his keynote address at the workshop, elaborated on the need to develop tolerant planting materials and research expertise to ensure the viability and sustainability of forest plantations.

Also presenting papers at the SFC workshop were researchers from Forest Research Institute of Malaysia (FRIM), major timber companies and government agencies from Sabah and Sarawak.

I T * \ A N D M f i B A S K WORKSHOP

V' - - I V

Wingfield (seated centre) and the participants including SFC chief executive officer Wong Ting Chung (seated third left) in a group photo.

Headline Forest plantations urged to invest in R&D on pest and disease MediaTitle Borneo Post (Kuching)

Date 27 Jul 2017 Color Full Color

Section Home Circulation 89,224

Page No 8 Readership 267,672

Language English ArticleSize 229 cm²

Journalist N/A AdValue RM 3,123

Frequency Daily (EM) PR Value RM 9,369

Referensi

Dokumen terkait

1 Australian and New Zealand Journal of Public Health 39 © 2020 The Authors Clinical trials are increasingly recognised as having an integral role in the Australian healthcare